early intervention tirzepatide

Early intervention with tirzepatide or semaglutide influences anti-atherosclerotic effects in ApoE knockout mice: Experts Fla

Experts Flag Semaglutide's Shortfall on Plaque

Experts Flag Semaglutide's Shortfall on Plaque In ApoE knockout mice, initiating semaglutide at 4 weeks reduces plaque density by 30% compared with placebo, but its overall plaque-burden impact trails newer agents. Early treatment therefore offers a measurable anti-atherosclerotic signal while leaving room for improvement. Medical Disclaimer: This article